全国6城市0~3岁婴幼儿运动发育评估量表的构建与评估  

Construction and evaluation of the Children Motor Development Assessment Scale for infants aged 0-3 years in six cities of China

作　　者：樊朝阳[1] 台学龙 何守森 古桂雄[4] 吴康敏[5] 李丽 张燕燕 谢露[8] 张瑞芳 卢游[5] 杨彦慧 果吉尔锑 王鸿源 宋婷婷 戴耀华[1] FAN Zhaoyang;TAI Xuelong;HE Shousen;GU Guixiong;WU Kangmin;LI Li;ZHANG Yanyan;XIE Lu;ZHANG Ruifang;LU You;YANG Yanhui;GUOJI Erti;WANG Hongyuan;SONG Tingting;DAI Yaohua(Department of Integrated Early Childhood Development,Capital Institute of Pediatrics,Beijing 102600,China;Fisk Beijing Health Technology Co Ltd;Department of Child Health Care,Shandong Maternal and Child Health Hospital;Department of Child Health Care,Children′s Hospital of Soochow University;West China Second University Hospital,Sichuan University;Department of Child Health Care,Shenzhen Luohu Maternity and Child Healthcare Hospital;Department of Child Health Care,Weihai Maternity and Child Health Care Hospital;Department of Child Health Care,Kunming Maternity and Child Care Hospital;Department of Child Health Care,Inner Mongolia Maternity and Child Health Care Hospital;Department of Child Health Care,Beijing Jingdu Children′s Hospital;National Research Institute for Family Planning,National Health Commission)

机构地区：[1]首都儿科研究所儿童早期综合发展研究室,北京102600 [2]菲斯克(北京)健康科技有限公司 [3]山东省妇幼保健院 [4]苏州大学附属儿童医院儿童保健科 [5]四川大学华西第二医院 [6]深圳市罗湖区妇幼保健院儿童保健科 [7]威海市妇幼保健院儿童保健科 [8]昆明市妇幼保健院儿童保健科 [9]内蒙古自治区妇幼保健院儿童保健科 [10]北京京都儿童医院儿童保健科 [11]国家卫健委科学技术研究所

出　　处：《中国儿童保健杂志》2024年第12期1359-1363,共5页Chinese Journal of Child Health Care

摘　　要：目的构建0~3岁婴幼儿运动发育评估量表(MDS)并评估其信度和效度,为我国婴幼儿运动发育情况进行科学有效的评估提供方便有效的实用工具。方法2019年7月—2021年4月,在全国6城市对0~3岁婴幼儿采用MDS进行运动能力发育评估。采用Cronbach′sα系数评价内部一致性信度指标。由两名不同评测者对25名儿童两周内进行两次MDS测评,来判断复测信度。效度评价以Gesell量表的粗大运动和精细运动分量表为标准进行Pearson相关性分析。对量表得分结果进行统计学分析。结果回收有效样本1019份,男童512人,女童507人。精细动作、粗大运动分量表和总量表的Cronbach′sα系数均>0.9,表明本量表有良好的内部一致性。精细运动分量表的重测信度为r=0.997(P<0.01),粗大运动分量表的重测信度为r=0.995(P<0.01)。效度检测结果显示Gesell精细动作分量表发育商与MDS精细动作发育商间具有相关性(r=0.71,P<0.05),Gesell粗大运动的发育商与MDS大运动发育商间具有相关性(r=0.73,P<0.05)。MDS得分随婴幼儿年龄增长呈增加趋势(P<0.01)。结论本研究构建的MDS运动发育筛查效能不亚于Gesell运动分量表,信效度检验提示量表内容效度达到标准水平,并且结构合理,适用性强,简单易操作,具有较好的筛查发育异常儿童的能力,符合儿童运动发育筛查、运动康复评估工作的需求。Objective To develop a Motor Development Scale(MDS)for infants aged 0-3years,and to evaluate its reliability and validity,so as to provide a convenient and effective practical tool for the scientific and effective assessment of motor development among infants in China.Methods From July 2019to April 2021,infants aged 0-3years from six cities nationwide were assessed for motor development using the MDS.The Cronbach′sαcoefficient was used to evaluate the internal consistency reliability.Two different evaluators conducted two MDS assessments within two weeks on 25 children to determine the test-retest reliability.The validity evaluation was performed using the Gross Motor and Fine Motor Subscales of the Gesell Scale as the gold standard for Pearson correlation analysis.Statistical analysis was conducted on the scale scores.Results A total of 1019valid samples were collected,including 512boys and 507girls.The Cronbach′sαcoefficients for the fine motor,gross motor subscales,and the total scale were all>0.9,indicating good internal consistency of the scale.The test-retest reliability for the fine motor subscale and gross motor subscale was 0.997 and 0.995,respectively(P<0.01).The validity test results showed a correlation between the Gesell fine motor developmental quotient(DQ)and the MDS fine motor DQ(r=0.71,P<0.05),as well as between the Gesell Gross Motor DQ and the MDS Gross Motor DQ(r=0.73,P<0.05).The MDS scores showed an increasing trend with the age of infants(P<0.01).Conclusions The MDS developed in this study has a motor development screening efficiency comparable to the Gesell Motor Subscales.The content validity of the scale meets standard levels,with a reasonable structure,strong applicability,simplicity,and ease of operation,and has a good ability to screen for children with developmental abnormalities,meeting the needs of motor development screening and motor rehabilitation assessment in children.

关 键 词：婴幼儿 运动发育测评 信度 效度 

分 类 号：R174[医药卫生—妇幼卫生保健]